---
title: Metformin as an antiaging drug
videoId: sFbghkE0WYo
---

From: [[⁨cleoabram⁩]] <br/> 

Metformin, a medication used for decades by people with diabetes to control blood sugar, has recently garnered attention as a potential anti-aging drug <a class="yt-timestamp" data-t="00:00:22">[00:00:22]</a>. Known for being very inexpensive, costing pennies per pill, it has become popular with wealthy individuals seeking to prolong their lives <a class="yt-timestamp" data-t="00:00:27">[00:00:27]</a>.

## Defining Anti-Aging Research

Dr. Nir Barzilai, an expert on aging, clarifies that genuine anti-aging research is not about finding a "fountain of youth" that can make an old person young again <a class="yt-timestamp" data-t="00:01:15">[00:01:15]</a>. Instead, researchers aim to delay the effects of aging, specifically the increased chance of dying from common diseases that escalates with age <a class="yt-timestamp" data-t="00:01:27">[00:01:27]</a>.

Dr. Barzilai suggests that the biology of aging itself drives age-related diseases like [[importance_of_early_detection_in_cancer_survival | cancer]], heart disease, and Alzheimer's <a class="yt-timestamp" data-t="00:01:51">[00:01:51]</a>. The theory is that if the accumulation of damage to our bodies over time could be delayed, the onset of these diseases might also be postponed, increasing longevity <a class="yt-timestamp" data-t="00:02:02">[00:02:02]</a>.

## The UK Study and its Implications

In 2014, a significant study from the UK involving approximately 180,000 people investigated the mortality rates of three groups:
*   People with diabetes taking [[metformins_effects_on_diabetes | Metformin]] <a class="yt-timestamp" data-t="00:02:36">[00:02:36]</a>
*   People with diabetes taking other non-metformin drugs <a class="yt-timestamp" data-t="00:02:40">[00:02:40]</a>
*   People without diabetes not taking any diabetes drugs <a class="yt-timestamp" data-t="00:02:43">[00:02:43]</a>

The study found that people with diabetes not taking Metformin had double the mortality rate compared to people without diabetes <a class="yt-timestamp" data-t="00:02:47">[00:02:47]</a>. Remarkably, people with diabetes who were taking Metformin, despite often being more obese and sick to begin with, had *less* mortality than people without diabetes <a class="yt-timestamp" data-t="00:02:54">[00:02:54]</a>.

### Caveats and Limitations

While these findings were intriguing, significant caveats exist for applying them directly to anti-aging:
*   **Correlation vs. Causation:** The UK study was retrospective, meaning it looked back at existing data rather than testing if Metformin *caused* the reduced mortality <a class="yt-timestamp" data-t="00:03:19">[00:03:19]</a>.
*   **Study Population:** Only people with diabetes were taking Metformin in this study, so it's unclear if the "dying less" effect applies to individuals without diabetes <a class="yt-timestamp" data-t="00:03:27">[00:03:27]</a>.

Regarding how Metformin works for anti-aging, much less is known compared to its established mechanism for diabetes. In diabetes, Metformin helps control high blood sugar levels by affecting how the body transports sugars to cells <a class="yt-timestamp" data-t="00:03:40">[00:03:40]</a>. For anti-aging in non-diabetics, the mechanism is not well understood <a class="yt-timestamp" data-t="00:03:56">[00:03:56]</a>. A contributing factor to this knowledge gap is the lack of incentive for pharmaceutical companies to fund expensive new [[current_research_on_metformin_and_its_limitations | research on Metformin]] since it's already a cheap, generic drug <a class="yt-timestamp" data-t="00:04:03">[00:04:03]</a>.

Despite these limitations, other studies have shown Metformin to have anti-aging effects in healthy mice and worms <a class="yt-timestamp" data-t="00:04:12">[00:04:12]</a>.

## The TAME Study: Targeting Aging with Metformin

To definitively determine if Metformin can delay aging in most people, more research is needed <a class="yt-timestamp" data-t="00:04:17">[00:04:17]</a>. Dr. Barzilai is leading this effort with the TAME (Targeting Aging with Metformin) study <a class="yt-timestamp" data-t="00:04:36">[00:04:36]</a>. This nationwide randomized trial will involve giving half the participants Metformin and the other half a placebo <a class="yt-timestamp" data-t="00:04:29">[00:04:29]</a>. The goal is to obtain FDA approval to repurpose Metformin as a drug that targets aging <a class="yt-timestamp" data-t="00:04:48">[00:04:48]</a>.

If successful, this research could establish that aging is treatable, allowing for the delay of damage accumulation and the common diseases that cause mortality <a class="yt-timestamp" data-t="00:05:06">[00:05:06]</a>. The potential impact is enormous, especially since Metformin is an existing and affordable medication <a class="yt-timestamp" data-t="00:05:17">[00:05:17]</a>.

## Personal Considerations for Metformin Use

Deciding whether to take Metformin for anti-aging, particularly without a diabetes diagnosis, involves weighing several factors <a class="yt-timestamp" data-t="00:05:44">[00:05:44]</a>:

1.  **Assessment of Existing Studies:** Evaluating the strength of current research, excluding the yet-to-be-completed TAME trial <a class="yt-timestamp" data-t="00:05:52">[00:05:52]</a>.
2.  **Urgency of Aging:** A personal assessment of how urgently one perceives the need to address aging <a class="yt-timestamp" data-t="00:05:57">[00:05:57]</a>.
3.  **Weighing Benefits Against Side Effects:** Considering the perceived benefits against [[potential_side_effects_and_considerations_of_metformin_use | potential side effects]] <a class="yt-timestamp" data-t="00:06:03">[00:06:03]</a>.

### Known Side Effects

[[potential_side_effects_and_considerations_of_metformin_use | Common side effects]] in the first week of Metformin use include early satiety (not feeling hungry), upset stomach, and diarrhea <a class="yt-timestamp" data-t="00:06:07">[00:06:07]</a>. The drug also impacts how the body responds to exercise; while muscle capacity may increase, muscle size might not be as significant <a class="yt-timestamp" data-t="00:06:20">[00:06:20]</a>.

Some individuals taking Metformin for anti-aging without diabetes are making the calculation that they do not want to wait for more studies, are content with existing research, accept the side effects, and feel the urgency of aging <a class="yt-timestamp" data-t="00:06:51">[00:06:51]</a>. Others, like the narrator, prefer to wait for more definitive studies before considering the medication <a class="yt-timestamp" data-t="00:07:22">[00:07:22]</a>.

## Broader Significance

Beyond Metformin, researchers are exploring various drugs for their potential anti-aging effects <a class="yt-timestamp" data-t="00:07:28">[00:07:28]</a>. The discovery of any option that meaningfully delays the effects of aging in most people would be profoundly significant, given the high mortality rates associated with age-related diseases:
*   18 million people die of heart disease every year <a class="yt-timestamp" data-t="00:07:44">[00:07:44]</a>.
*   10 million people die of [[importance_of_early_detection_in_cancer_survival | cancer]] annually <a class="yt-timestamp" data-t="00:07:48">[00:07:48]</a>.
*   55 million people live with Alzheimer's or other dementias <a class="yt-timestamp" data-t="00:07:50">[00:07:50]</a>.